Skip to main content
Log in

Early Parity Significantly Elevates Mammary Tumor Incidence in MMTV-c-myc Transgenic Mice

  • Published:
Transgenic Research Aims and scope Submit manuscript

Abstract

Female transgenic mice, in which a murine c-myc gene has been placed under the transcriptional control of the mouse mammary tumor virus long terminal repeat, are prone to developing mammary adenocarcinomas. Owing to the manner in which these mammary tumors develop, it is clear that exogenous expression of the c-myc transgene is necessary to but insufficient for murine mammary tumorigenesis. The genetic background of study mice has been shown to influence the phenotype induced by different transgenes; furthermore, mammary tumor initiation and progression induced by different transgenes has been shown to be susceptible to significant modification with alterations in and mixing of the genetic background of the study mice. We bred MMTV-c-myc transgenic mice onto a mixed genetic background that resulted in a very significant suppression of mammary tumor incidence for parous mice, bred continuously starting at 10 weeks of age. In this paper, we show that mammary tumor incidence is significantly elevated in these mixed background MMTV-c-myc transgenic mice when they are bred continuously, starting at 7 weeks of age. Early breeding of these mice did not influence mammary tumor multiplicity, latency, histopathology, or number of pregnancies at time of tumor development. These results are the first to demonstrate that breeding age influences mammary tumor incidence in MMTV-c-myc transgenic mice. They suggest that mammary gland susceptibility to tumorigenesis, resulting from the expression of c-myc, may vary with glandular development as is seen for chemical carcinogens.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Amundadottir LT, Johnson MD, Merlino G, Smith GH and Dickson RB (1995) Synergistic interaction of transforming growth factor α and c-myc in mouse mammary and salivary gland tumorigenesis. Cell Growth Diff 6: 737–748.

    Google Scholar 

  • Cardiff RD (1996) The biology of mammary transgenes: five rules. J Mammary Gland Biol Neoplasia 1: 61–73.

    Google Scholar 

  • Cardiff RD, Anver MR, Gusterson BA, Hennighausen L, Jensen RA, Merino MJ et al. (2000) The mammary pathology of genetically engineered mice: the Consensus report and recommendations from the Annapolis meeting. Oncogene 19: 968–988.

    Google Scholar 

  • Desai KV, Xiao N, Wang W, Gangi L, Greene J, Powell JI et al. (2002) Initiating oncogenic event determines gene-expression patterns of human breast cancer models. Proc Natl Acad Sci USA 99: 6967–6972.

    Google Scholar 

  • Doerfler W, Schubbert R, Heller H, Kämmer C, Hilger-Eversheim K, Knoblauch M et al. (1997) Integration of foreign DNA and its consequences in mammalian systems. Trends Biotechnol 15: 297–301.

    Google Scholar 

  • Doetschmann T (1999) Interpretation of phenotype in genetically engineered mice. Lab Anim Sci 49: 137–143.

    Google Scholar 

  • Donehower LA, Andre J, Berard DS, Wolford RG and Hager GL (1980) Construction and characterization of molecular clones containing integrated mouse mammary tumor virus sequences. Cold Spring Harbor Symp Quant Biol 44: 1153–1159.

    Google Scholar 

  • Donehower LA, Huang AL and Hager GL (1981) Regulatory and coding potential of the mouse mammary tumor virus long terminal redundancy. J Virol 37: 226–238.

    Google Scholar 

  • Hennighausen L and Robinson GW (1998) Think globally, act locally: the making of a mouse mammary gland. Genes Dev 12: 449–455.

    Google Scholar 

  • Le Voyer T, Lu Z, Babb J, Lifsted T, Williams M and Hunter KW (2000) An epistatic interaction controls the latency of a transgene-induced mammary tumor. Mamm Genome 11: 883–889.

    Google Scholar 

  • Leder A, Pattengale PK, Kuo A, Stewart TA and Leder P (1986) Consequences of widespread deregulation of the c-myc gene in transgenic mice: multiple neoplasms and normal development. Cell 45: 485–495.

    Google Scholar 

  • Lifsted T, Le Voyer T, Williams M, Muller W, Klein-Szantos A, Buetow KH et al. (1998) Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression. Int J Cancer 77: 640–644.

    Google Scholar 

  • MacLeod KF and Jacks T (1999) Insights into cancer from transgenic mouse models. J Path 187: 43–60.

    Google Scholar 

  • Mangues R, Schwartz S, Seidman I and Pellicer A (1995) Promoter demethylation isMMTV/N-rasN transgenic mice required for transgene expression and tumorigenesis. Mol Carcinogen 14: 94–102.

    Google Scholar 

  • Robertson KD (2002) DNA methylation and chromatin – unraveling the tangled web. Oncogene 21: 5361–5379.

    Google Scholar 

  • Rowse GJ, Ritland SR and Gendler SJ (1998) Genetic modulation of neu proto-oncogene-induced mammary tumorigenesis. Cancer Res 58: 2675–2679.

    Google Scholar 

  • Russo J and Russo IH (1996) Experimentally induced mammary tumors in rats. Breast Cancer Res Treat 39: 7–20.

    Google Scholar 

  • Stewart TA, Pattengale PK and Leder P (1984) Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell 38: 627–637.

    Google Scholar 

  • Zhou H, Chen W, Qin X, Lee K, Liu L, Markowitz SD et al. (2001) MMTV promoter hypermethylation is linked to spontaneous and MNU associated c-neu expression and mammary carcinogenesis in MMTV-c-neu transgenic mice. Oncogene 20: 6009–6017.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Robert B. Dickson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jamerson, M.H., Johnson, M.D., Furth, P.A. et al. Early Parity Significantly Elevates Mammary Tumor Incidence in MMTV-c-myc Transgenic Mice. Transgenic Res 12, 747–750 (2003). https://doi.org/10.1023/B:TRAG.0000005247.69329.ca

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:TRAG.0000005247.69329.ca

Navigation